BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chou J, Platt CD, Habiballah S, Nguyen AA, Elkins M, Weeks S, Peters Z, Day-Lewis M, Novak T, Armant M, Williams L, Rockowitz S, Sliz P, Williams DA, Randolph AG, Geha RS; Taking on COVID-19 Together Study Investigators. Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C). J Allergy Clin Immunol 2021:S0091-6749(21)01052-6. [PMID: 34224783 DOI: 10.1016/j.jaci.2021.06.024] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
Number Citing Articles
1 Roarty C, Waterfield T. Review and future directions for PIMS-TS (MIS-C). Arch Dis Child 2022:archdischild-2021-323143. [PMID: 35012934 DOI: 10.1136/archdischild-2021-323143] [Reference Citation Analysis]
2 Miqdhaadh A, Imad HA, Fazeena A, Ngamprasertchai T, Nguitragool W, Nakayama EE, Shioda T. Multisystem Inflammatory Syndrome Associated with SARS-CoV-2 Infection in an Adult: A Case Report from the Maldives. Trop Med Infect Dis 2021;6:187. [PMID: 34698279 DOI: 10.3390/tropicalmed6040187] [Reference Citation Analysis]
3 Wang L, Li G, Yuan C, Yang Y, Ling G, Zheng J, Zhou Y, Zhang T, Lin W, Lin Z. Progress in the Diagnosis and Treatment of COVID-19 in Children: A Review. Int J Gen Med 2021;14:8097-108. [PMID: 34795516 DOI: 10.2147/IJGM.S335888] [Reference Citation Analysis]
4 Suksatan W, Chupradit S, Yumashev AV, Ravali S, Shalaby MN, Mustafa YF, Kurochkin A, Siahmansouri H. Immunotherapy of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 through mesenchymal stem cells. International Immunopharmacology 2021;101:108217. [DOI: 10.1016/j.intimp.2021.108217] [Reference Citation Analysis]
5 Suksatan W, Chupradit S, Yumashev AV, Ravali S, Shalaby MN, Mustafa YF, Kurochkin A, Siahmansouri H. Immunotherapy of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 through mesenchymal stem cells. Int Immunopharmacol 2021;101:108217. [PMID: 34627083 DOI: 10.1016/j.intimp.2021.108217] [Reference Citation Analysis]
6 Chou J, Thomas PG, Randolph AG. Immunology of SARS-CoV-2 infection in children. Nat Immunol 2022;23:177-85. [PMID: 35105983 DOI: 10.1038/s41590-021-01123-9] [Reference Citation Analysis]
7 Yang J, Yan Y, Zhong W. Application of omics technology to combat the COVID-19 pandemic. MedComm (2020) 2021;2:381-401. [PMID: 34766152 DOI: 10.1002/mco2.90] [Reference Citation Analysis]
8 Bucciol G, Tangye SG, Meyts I. Coronavirus disease 2019 in patients with inborn errors of immunity: lessons learned. Curr Opin Pediatr 2021;33:648-56. [PMID: 34734915 DOI: 10.1097/MOP.0000000000001062] [Reference Citation Analysis]
9 Dhaliwal M, Tyagi R, Malhotra P, Barman P, Loganathan SK, Sharma J, Sharma K, Mondal S, Rawat A, Singh S. Mechanisms of Immune Dysregulation in COVID-19 Are Different From SARS and MERS: A Perspective in Context of Kawasaki Disease and MIS-C. Front Pediatr 2022;10:790273. [DOI: 10.3389/fped.2022.790273] [Reference Citation Analysis]
10 Niemi MEK, Daly MJ, Ganna A. The human genetic epidemiology of COVID-19. Nat Rev Genet 2022. [PMID: 35501396 DOI: 10.1038/s41576-022-00478-5] [Reference Citation Analysis]
11 Vella LA, Rowley AH. Current Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome in Children. Curr Pediatr Rep 2021;:1-10. [PMID: 34692237 DOI: 10.1007/s40124-021-00257-6] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Muscogiuri G, Bettini S, Boschetti M, Barrea L, Savastano S, Colao A; Obesity Programs of nutrition, Education, Research and Assessment (OPERA) group. Low-grade inflammation, CoVID-19, and obesity: clinical aspect and molecular insights in childhood and adulthood. Int J Obes (Lond) 2022. [PMID: 35393519 DOI: 10.1038/s41366-022-01111-5] [Reference Citation Analysis]
13 Sharma C, Ganigara M, Galeotti C, Burns J, Berganza FM, Hayes DA, Singh-Grewal D, Bharath S, Sajjan S, Bayry J. Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison. Nat Rev Rheumatol 2021;17:731-48. [PMID: 34716418 DOI: 10.1038/s41584-021-00709-9] [Reference Citation Analysis]
14 Brück N, Schütz C, Kallinich T. Das Pädiatrische Inflammatorische Multisystem Syndrom (PIMS) in der COVID-19 Pandemie. Aktuelle Rheumatologie 2022;47:117-27. [DOI: 10.1055/a-1715-5027] [Reference Citation Analysis]
15 Schulert GS, Blum SA, Cron RQ. Host genetics of pediatric SARS-CoV-2 COVID-19 and multisystem inflammatory syndrome in children. Curr Opin Pediatr 2021;33:549-55. [PMID: 34534994 DOI: 10.1097/MOP.0000000000001061] [Reference Citation Analysis]
16 Lim L, Lim SJ, Loy JS, Ng DC. Multisystem inflammatory syndrome in children (MIS-C) occurring in temporal proximity between siblings. BMJ Case Rep 2021;14:e246066. [PMID: 34531241 DOI: 10.1136/bcr-2021-246066] [Reference Citation Analysis]